Form 4: Definitive Healthcare CEO Sells Shares for Tax Withholding

Definitive Healthcare CEO Kevin Coop reported a transaction involving the sale of 37,593 shares of Class A Common Stock to cover tax obligations upon the vesting of Restricted Stock Units.

Summary

• Kevin Coop, CEO of Definitive Healthcare Corp., engaged in a transaction on April 1, 2026.
• The transaction involved the disposal of 37,593 shares of Class A Common Stock.
• These shares were sold at a price of $1.09 per share.
• The disposal was to satisfy the reporting person's tax withholding obligations related to the vesting and settlement of previously reported RSUs.
• Following this transaction, Coop beneficially owns 5,078,872 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine tax-related transaction for RSU vesting and does not necessarily indicate a negative outlook on the company's performance by the CEO.

Negatives

• The CEO sold a portion of his holdings, which could be perceived negatively by the market, although it was for tax withholding purposes.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it solely reports a past transaction.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those involving sales by C-suite executives, are closely watched by investors. While this transaction is explicitly for tax withholding related to RSU vesting, a common occurrence, any significant sale can still draw attention. Definitive Healthcare operates in the healthcare technology sector, a space characterized by rapid innovation and data utilization.

Stakeholder Impact

• Shareholders: May observe the transaction, but the explanation for tax withholding should mitigate concerns about the CEO's confidence in the company.

Key Dates

Keywords

Form 4, SEC Filing, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Definitive Healthcare Corp., Kevin Coop, CEO